期刊文献+

正常高值血压患者高敏C反应蛋白与尿微量清蛋白的相关性 被引量:1

Association of High Sensitivity C-reaction Protein and Albuminuria with Prehypertension
下载PDF
导出
摘要 目的观察正常高值血压患者血清高敏C反应蛋白(hs-CRP)与尿微量清蛋白(ALB)的水平,分析两者之间的相关性。方法选择正常高值血压患者110例,对照组为同期体检健康者87例,用ELISA法分别测定血清hs-CRP、ALB;空腹血糖(FBG)、三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL)、体重指数(BMI)。结果正常高值血压组血清hs-CRP、ALB水平显著高于对照组(P<0.05);且存在性别差异,男性显著高于女性(P<0.05)。hs-CRP与ALB呈正相关(P<0.01,r=0.47),TC、TG、BMI、FBG、LDL均与二者呈正相关(P<0.05)。结论正常高值血压患者血清hs-CRP、ALB水平明显升高,提示机体已存在炎症反应。TC、TG、BMI、FBG、LDL均是炎症反应的相关因素,雌激素可能对女性心血管系统有保护作用。 ObjectiveTo investigate the changes of serum high sensitivity C-reactive protein level (hs CRP)and albuminuria (ALB) level in patients with prehypertension and to investigate the relationship between hs CRP and ALB. MethodsTotal FBG,TC,TG,BMI and LDL were measured in 110 patients with prehypertension and 87 normal controls. Serum CRP and ALB concentration was measured by ELISA. ResultsSerum hs- CRP, urinary albumin concentration in patients with prehypertension was significantly high and had difference between male and female (P〈0.05). hs-CRP and ALB had positive correlation with TC, TG, BMI, FBG and LDL (All P〈0.05) .ConclusionThe serum hs- CRP and ALB level increased obviously in the patient with prehypertension,which indicated that an inflammation reaction existed in body.The elevated levels of TC, TG, FBG, LDL and BMI all correlate with inflammation. Estrogen may have protective effects on the female cardiovascular system.
出处 《医学研究杂志》 2010年第1期93-95,共3页 Journal of Medical Research
关键词 正常高值血压 炎症反应 高敏C反应蛋白 尿微量清蛋白 雌激素 Prehypertension Inflammatory reaction hs CRP Albuminuria Estrogen
  • 相关文献

参考文献8

  • 1Chobanian AV,Bakris GL,Black HR,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure:the JNC7 report. JAMA,2003,289: 2560 - 2572.
  • 2王薇,赵冬,孙佳艺,刘静,刘军,秦兰萍,刘飒,吴兆苏.中国正常高值血压人群的心血管病发病危险[J].中华高血压杂志,2007,15(12):984-987. 被引量:98
  • 3Clansen P,Jenserl J. S, Jensen J, et al. Elevated urjnary albuminexcretion is associated with impaired arterial dilatory capacity in clinically healthy sl ects. Circulation ,2001,103 : 1869 - 1874.
  • 4Jay PG, Geoge LB. Microalbuminuria :marker of vascular dysfunction, risk factorfor cardiovascular disease. Vascular medicine, 2002,7:35 - 43.
  • 5RobertoP, Dell'Omo G, Di Bello V, et al. Low - Grade Inflammation and Microalbuminuria in Hypertension. Arteriosclerosis, Thrombosis, and Vascular Biolog,2004, 24:2414.
  • 6Hashimoto H, Kitagawa K, Hougaku H, et al. Relationship between C - reactive protein and progression of early carotidatherosclerosis in hypertensive subjects. Stroke, 2004, 35:1625 - 1630.
  • 7Jay PG, Gcoge LB. Microalbuminuria :marker of vascular dysfunction, risk factorfor cardiovascular disease. Vascular medicine, 2002,7 : 35 - 43.
  • 8Dubey RK, Jack son EK, Gillesp ie DG, et al. Clinically used estrogens differentially inh ibit human aortic smooth muscle cell growth and mitogen - activated pro rein kinase activity. A rterioscler Thromb V asc Bio l. 2000. 20:964 -972.

二级参考文献10

  • 1王薇,赵冬,刘静,孙佳艺,吴桂贤,曾哲淳,刘军,秦兰萍,吴兆苏.中国35~64岁人群血压水平与10年心血管病发病危险的前瞻性研究[J].中华内科杂志,2004,43(10):730-734. 被引量:147
  • 2孙佳艺,赵冬,王薇,刘静,吴桂贤,王文化,李岩,吴兆苏.北京地区2740人的血压水平10年(1992-2002)变化情况[J].高血压杂志,2005,13(2):115-119. 被引量:130
  • 3[1]Prospective Studies Collaboration.Age-specific relevance of usual blood pressure to vascular mortality:a meta-analysis of individual data for one million adults in 61 prospective studies[J].Lancet,2002,360:1903-1913.
  • 4[3]Chobanian AV,Bakris GL,Black HR,et al.National heart,lung and blood institute joint national committee on prevention,detection,evaluation,and treatment of high blood pressure; national high blood pressure education program coordinating committee.The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure:the JNC 7 report[J].JAMA,2003,289:2560-2572.
  • 5[5]World Health Organization.Multination monitoring of treads and determinants in cardiovascular disease (MONICA project) and manual of operation[M].Cardiovascular Disease Unit,Geneva,1993.
  • 6[6]Liszka HA,Mainous III AG,King DE,et al.Prehypertension and cardiovascular morbidity[J].Ann Fam Med,2005,3:294-299.
  • 7[7]Vasan RS,Larson MG,Leip EP,et al.Impact of high-normal blood pressure on the risk of cardiovascular disease[J].N Engl J Med,2001,345:1291-1297.
  • 8[8]Mainous AG,Everett CJ,Liszka H,et al.Prehypertension and mortality in a nationally representative cohort[J].Am J Cardiol,2004,94:1496-1500.
  • 9[9]Hsia J,Margolis KL,Eaton CB,et al.Prehypertension and cardiovascular disease risk in the women's health initiative[J].Circulation,2007,115.855-860.
  • 10[10]Qureshi AI,Suri MFK,Kirmani JF,et al.Is prehypertension a risk factor for cardiovascular diseases[J].Stroke,2005,36:1859-1863.

共引文献97

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部